These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2463335

  • 1. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups.
    Dewar KM, Reader TA.
    J Neurochem; 1989 Feb; 52(2):472-82. PubMed ID: 2463335
    [Abstract] [Full Text] [Related]

  • 2. Specific [3H]raclopride binding to neostriatal dopamine D2 receptors: role of disulfide and sulfhydryl groups.
    Reader TA, Molina-Holgado E, Lima L, Boulianne S, Dewar KM.
    Neurochem Res; 1992 Aug; 17(8):749-59. PubMed ID: 1379349
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum. Equilibrium binding, kinetics and selectivity.
    Reader TA, Grondin L, Montreuil B, Dewar KM.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):617-25. PubMed ID: 2575710
    [Abstract] [Full Text] [Related]

  • 4. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex.
    Gottberg E, Diop L, Montreuil B, Reader TA.
    Neurochem Res; 1989 May; 14(5):419-26. PubMed ID: 2526301
    [Abstract] [Full Text] [Related]

  • 5. Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.
    Braestrup C, Andersen PH.
    J Neurochem; 1987 Jun; 48(6):1667-72. PubMed ID: 2952762
    [Abstract] [Full Text] [Related]

  • 6. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: evidence for heterogeneities in affinity states and cortical distribution.
    Reader TA, Brière R, Gottberg E, Diop L, Grondin L.
    J Neurochem; 1988 Feb; 50(2):451-63. PubMed ID: 2961849
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 8. Stereospecific binding of a new benzazepine, [3H]SCH23390, in cortex and neostriatum.
    Brière R, Diop L, Gottberg E, Grondin L, Reader TA.
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1507-11. PubMed ID: 2889517
    [Abstract] [Full Text] [Related]

  • 9. Evidence for the participation of disulfide and sulfhydril groups in the specific binding of [3H]prazosin in cerebral cortex.
    Reader TA, Brière R.
    Neurochem Res; 1985 Jan; 10(1):107-22. PubMed ID: 2984594
    [Abstract] [Full Text] [Related]

  • 10. Involvement of a disulfide bond in the binding of flunitrazepam to the benzodiazepine receptor from bovine cerebral cortex.
    Otero de Bengtsson MS, Lacorazza HD, Biscoglio de Jiménez Bonino MJ, Medina JH.
    J Neurochem; 1993 Feb; 60(2):536-42. PubMed ID: 8380435
    [Abstract] [Full Text] [Related]

  • 11. Binding of [3H]SCH23390 to a non-dopaminergic site in bovine kidney.
    Hollis CM, Turner JD, Strange PG.
    Biochem Pharmacol; 1992 May 08; 43(9):1947-55. PubMed ID: 1375829
    [Abstract] [Full Text] [Related]

  • 12. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW, Stanford EJ, Wyrick SW, Mailman RB.
    J Neurochem; 1985 Nov 08; 45(5):1601-11. PubMed ID: 2864398
    [Abstract] [Full Text] [Related]

  • 13. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
    Reader TA, Molina-Holgado E, Dewar KM.
    Mol Neurobiol; 1992 Nov 08; 6(4):425-50. PubMed ID: 1285933
    [Abstract] [Full Text] [Related]

  • 14. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK, Ross GM, Bajwa SB, Mishra RK.
    Neurochem Res; 1990 Jun 08; 15(6):647-57. PubMed ID: 1977093
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
    Cincotta M, de Vries DJ, Beart PM.
    Neurosci Lett; 1985 Oct 24; 61(1-2):85-9. PubMed ID: 2867505
    [Abstract] [Full Text] [Related]

  • 16. Studies on the structure of the ligand-binding site of the brain D1 dopamine receptor.
    Hollis CM, Strange PG.
    Biochem Pharmacol; 1992 Jul 22; 44(2):325-34. PubMed ID: 1386511
    [Abstract] [Full Text] [Related]

  • 17. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R, López MG, del Valle M, Naranjo JR, Mellström B, García AG.
    Mol Pharmacol; 1995 Jan 22; 47(1):40-50. PubMed ID: 7838132
    [Abstract] [Full Text] [Related]

  • 18. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ, Battaglia G, Norman AB, Iorio LC, Creese I.
    Eur J Pharmacol; 1986 Feb 11; 121(1):31-8. PubMed ID: 2869957
    [Abstract] [Full Text] [Related]

  • 19. Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors.
    Fuxe K, von Euler G, Finnman UB, Agnati LF.
    Acta Physiol Scand; 1989 Jun 11; 136(2):295-6. PubMed ID: 2528887
    [No Abstract] [Full Text] [Related]

  • 20. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
    Scheuhammer AM, Cherian MG.
    Biochem Pharmacol; 1985 Oct 01; 34(19):3405-13. PubMed ID: 3931643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.